Catalent, Inc. and Thermo Fisher Scientific, Inc. – Notable Market Players in Clinical Trial Supplies Market
Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. Also, the implementation of more stringent handling requirements for a type of biopharmaceutical products starting clinical trials, clinical trial supplies strategy needs to be continuously improved.
Several players performing in the market have undertaken various organic growth strategies in the clinical trial supplies market. The clinical trial supplies market majorly consists of players such as Catalent, Inc., Thermo Fisher Scientific, Inc. Almac Group, Parexel International Corporation, Biocair, UDG Healthcare plc (Sharp), PCI Healthcare Services, Owens & Minor Inc., KLIFO, Rubicon Research Pvt. Ltd., among others. Many organic strategies, such as product launches, expansion, and relocation in the clinical trial supplies market, have happened in the definite increase of the market. Product launches support the company to strengthen its product offering and the customer base, which enables the company to maintain a stable situation in the market. Furthermore, employing development activities, it is clear to venture into untapped markets and use the opportunities being offered.
Below is the list of the growth approaches done by the players working in the clinical trial supplies market:
|
Year |
News |
|
February 2020 |
PCI Pharma Services acquired Bellwyck Pharma Services as part of its global expansion in Clinical Trial Services in Canada and the Continental European region. |
|
September 2019 |
PCI Healthcare Services expanded its clinical services facility in Rockford to about 30,000 sq. ft. This scale of the facility has helped the company to deliver increased flexibility and scalability for its services related to primary and secondary packaging, labeling, and 2-8°C cold chain storage. |
|
April 2019 |
UDG Healthcare plc (Sharp), received approval from the Medicines and Healthcare Product Regulatory Agency (MHRA) to commence of production at its Clinical Services Centre of Excellence in Rhymney, UK. |
|
March 2019 |
Almac Group launched ‘Almac ONE,’ a first unified clinical trial supply solution. The launch of this solution has redefined the clinical supply chain experience, which has created a responsive end-to-end process that enhances visibility and accuracy throughout the lifecycle of a clinical study conducted by the customers. |
|
October 2018 |
Sharp is the business unit of UDG Healthcare plc that operates in the global clinical trial supplies market. Sharp has entered into a long-term strategic partnership with Santen Pharmaceuticals, as the business partnerships to Santen Pharmaceuticals will provide pharmaceutical packaging services from Heerenveen in the Netherlands. |
